CN112739335A - 用于治疗眼表损伤和干燥症状的眼用组合物 - Google Patents

用于治疗眼表损伤和干燥症状的眼用组合物 Download PDF

Info

Publication number
CN112739335A
CN112739335A CN201980062052.2A CN201980062052A CN112739335A CN 112739335 A CN112739335 A CN 112739335A CN 201980062052 A CN201980062052 A CN 201980062052A CN 112739335 A CN112739335 A CN 112739335A
Authority
CN
China
Prior art keywords
composition
patient
ocular surface
dryness
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980062052.2A
Other languages
English (en)
Chinese (zh)
Inventor
M·贝尔
D·维伦
S·克罗斯
T·施吕特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novaliq GmbH
Original Assignee
Novaliq GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq GmbH filed Critical Novaliq GmbH
Publication of CN112739335A publication Critical patent/CN112739335A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201980062052.2A 2018-09-22 2019-09-20 用于治疗眼表损伤和干燥症状的眼用组合物 Pending CN112739335A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP18196126 2018-09-22
EP18196126.9 2018-09-22
EP18198440 2018-10-03
EP18198440.2 2018-10-03
EP18202041.2 2018-10-23
EP18202041 2018-10-23
PCT/EP2019/075406 WO2020058504A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Publications (1)

Publication Number Publication Date
CN112739335A true CN112739335A (zh) 2021-04-30

Family

ID=68240699

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980062052.2A Pending CN112739335A (zh) 2018-09-22 2019-09-20 用于治疗眼表损伤和干燥症状的眼用组合物

Country Status (11)

Country Link
US (2) US20210346313A1 (https=)
EP (1) EP3852734A1 (https=)
JP (1) JP2022500461A (https=)
KR (1) KR20210080388A (https=)
CN (1) CN112739335A (https=)
AU (2) AU2019342426A1 (https=)
CA (1) CA3111873A1 (https=)
IL (1) IL281516A (https=)
PH (1) PH12021550621A1 (https=)
SG (1) SG11202102818YA (https=)
WO (1) WO2020058504A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348777B (zh) 2015-09-30 2020-04-28 诺瓦利克有限责任公司 半氟化化合物和其组合物
USRE50060E1 (en) 2016-06-23 2024-07-30 Novaliq Gmbh Topical administration method
ES2969758T3 (es) 2016-09-22 2024-05-22 Novaliq Gmbh Composiciones farmacéuticas para usar en la terapia de la blefaritis
US10813976B2 (en) 2016-09-23 2020-10-27 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
PT3399962T (pt) 2016-12-23 2020-09-03 Novaliq Gmbh Composição oftálmica para o tratamento da doença do olho seco
CA3058097C (en) 2017-04-21 2024-01-02 Novaliq Gmbh Iodine compositions
KR20200059272A (ko) 2017-09-27 2020-05-28 노바리크 게엠베하 안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
EP3758676A1 (en) 2018-03-02 2021-01-06 Novaliq GmbH Pharmaceutical compositions comprising nebivolol
KR102882058B1 (ko) 2018-03-28 2025-11-07 노바리크 게엠베하 티몰롤을 포함하는 약제학적 조성물
JP2021522219A (ja) 2018-04-27 2021-08-30 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
CN113710228A (zh) 2019-02-13 2021-11-26 诺瓦利克有限责任公司 用于治疗眼部新生血管形成的组合物和方法
US12419933B2 (en) 2019-09-06 2025-09-23 Novaliq Gmbh Ophthalmic composition for the treatment of uveitis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
US10105441B2 (en) * 2007-08-16 2018-10-23 The Schepens Eye Research Institute, Inc. Method for inhibiting or reducing dry eye disease by IL-1Ra
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
CN113679697A (zh) 2012-09-12 2021-11-23 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
DK3181119T3 (da) * 2012-09-12 2019-09-16 Novaliq Gmbh Semifluorerede alkansammensætninger til anvendelse ved behandling af keratoconjunctivitis sicca
CN106999402B (zh) * 2014-10-09 2020-10-27 梅迪普罗都司股份有限公司 睫毛用清洗剂
CN108348777B (zh) * 2015-09-30 2020-04-28 诺瓦利克有限责任公司 半氟化化合物和其组合物
ES2969758T3 (es) * 2016-09-22 2024-05-22 Novaliq Gmbh Composiciones farmacéuticas para usar en la terapia de la blefaritis
CN111182893A (zh) * 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物

Also Published As

Publication number Publication date
US20250295607A1 (en) 2025-09-25
PH12021550621A1 (en) 2022-02-14
AU2025204313A1 (en) 2025-06-26
AU2019342426A1 (en) 2021-05-20
CA3111873A1 (en) 2020-03-26
EP3852734A1 (en) 2021-07-28
KR20210080388A (ko) 2021-06-30
SG11202102818YA (en) 2021-04-29
US20210346313A1 (en) 2021-11-11
IL281516A (en) 2021-04-29
JP2022500461A (ja) 2022-01-04
WO2020058504A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
US20250295607A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
US12569452B2 (en) Ophthalmic compositions comprising F6H8
US12059449B2 (en) Ophthalmic composition for treatment of dry eye disease
JP7465453B2 (ja) ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
JP2025004186A (ja) 眼表面疼痛を治療する方法
RU2806212C2 (ru) Офтальмологические композиции для лечения повреждения поверхности глаза и симптомов сухости глаз
CA3076567C (en) Ophthalmic compositions comprising f6h8
RU2828769C2 (ru) Офтальмологические композиции для лечения синдрома сухого глаза
HK40028751A (en) Ophthalmic compositions comprising f6h8
HK40114301A (en) Ophthalmic composition for treatment of dry eye disease
HK40058504A (en) Ophthalmic composition for treatment of dry eye disease
HK40058504B (en) Ophthalmic composition for treatment of dry eye disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination